CD30 / TNFRSF8 (Hodgkin & Reed-Sternberg Cell Marker); Clone Ber-H2 (Concentrate)
Immunogen: Cancer cell line established from a patient with Hodgkin's disease of T-cell lineage
Isotype: IgG1, kappa
Species Reactivity: Human. Others not known.
Positive Control: Hodgkin's lymphoma
Specificity: Recognizes a single chain glycoprotein of 105/120kDa, identified as CD30/Ki-1. This Mab distinguishes large cell lymphomas derived from activated lymphoid cells from histiocytic malignancies and lymphomas derived from resting and precursor lymphoid cells or from anaplastic carcinomas.